AI-based selection of tumor regions for molecular analysis will provide samples with higher tumor cellularity, improving the sensitivity and reliability of molecular tests. To take full advantage current manual macro-dissection must be replaced by a fully digital, automated process.
Xyall has introduced the Tissector solution that provides full integration from AI-based selection to automatic dissection. The selected regions are automatically mapped and dissected by a scraping robot with high precision. The quality of dissection is monitored using digital pre- and post-dissection images to have full traceability of samples going into the molecular workup. Xyall’s CTO, Reinhold Wimberger, will introduce the Tissector technology and discuss the benefits of better and more predictable sample quality for optimal NGS test results next to a more efficient lab workflow.